A novel anti-pruritic: Topical co-administration of high molecular weight hyaluronan (HMWH) with protamine, a transdermal transport enhancer
- PMID: 38728068
- PMCID: PMC11088296
- DOI: 10.1177/17448069241254455
A novel anti-pruritic: Topical co-administration of high molecular weight hyaluronan (HMWH) with protamine, a transdermal transport enhancer
Abstract
Pruritis, the sensation of itch, is produced by multiple substances, exogenous and endogenous, that sensitizes specialized sensory neurons (pruriceptors and pruri-nociceptors). Unfortunately, many patients with acute and chronic pruritis obtain only partial relief when treated with currently available treatment modalities. We recently demonstrated that the topical application of high molecular weight hyaluronan (HMWH), when combined with vehicles containing transdermal transport enhancers, produce potent long-lasting reversal of nociceptor sensitization associated with inflammatory and neuropathic pain. In the present experiments we tested the hypothesis that the topical formulation of HMWH with protamine, a transdermal transport enhancer, can also attenuate pruritis. We report that this topical formulation of HMWH markedly attenuates scratching behavior at the nape of the neck induced by serotonin (5-hydroxytryptamine, 5-HT), in male and female rats. Our results support the hypothesis that topical HMWH in a transdermal transport enhancer vehicle is a strong anti-pruritic.
Keywords: 5-hydroxytryptamine; Hyaluronan; itch; topical anti-pruritic; transdermal transporter.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures

Similar articles
-
PI3Kγ/AKT Signaling in High Molecular Weight Hyaluronan (HMWH)-Induced Anti-Hyperalgesia and Reversal of Nociceptor Sensitization.J Neurosci. 2021 Oct 6;41(40):8414-8426. doi: 10.1523/JNEUROSCI.1189-21.2021. Epub 2021 Aug 20. J Neurosci. 2021. PMID: 34417329 Free PMC article.
-
CD44 Signaling Mediates High Molecular Weight Hyaluronan-Induced Antihyperalgesia.J Neurosci. 2018 Jan 10;38(2):308-321. doi: 10.1523/JNEUROSCI.2695-17.2017. Epub 2017 Nov 24. J Neurosci. 2018. PMID: 29175954 Free PMC article.
-
Topical coapplication of hyaluronan with transdermal drug delivery enhancers attenuates inflammatory and neuropathic pain.Pain. 2023 Dec 1;164(12):2653-2664. doi: 10.1097/j.pain.0000000000002993. Epub 2023 Jul 18. Pain. 2023. PMID: 37467181 Free PMC article.
-
Microemulsions as transdermal drug delivery vehicles.Adv Colloid Interface Sci. 2006 Nov 16;123-126:369-85. doi: 10.1016/j.cis.2006.05.014. Epub 2006 Jul 14. Adv Colloid Interface Sci. 2006. PMID: 16843424 Review.
-
The selection and design of topical and transdermal agents: a review.J Investig Dermatol Symp Proc. 1998 Aug;3(2):131-5. doi: 10.1038/jidsymp.1998.27. J Investig Dermatol Symp Proc. 1998. PMID: 9734827 Review.
References
-
- Ring J. Itch - the major symptom of skin disease and yet still enigmatic. J Eur Acad Dermatol Venereol 2021; 35: 780. - PubMed
-
- Pereira MP, Schmelz M, Ständer S. Mechanisms and therapeutic targets for neuropathic itch. Curr Opin Neurobiol 2022; 75: 102573. - PubMed
-
- Misery L, Pierre O, Le Gall-Ianotto C, Lebonvallet N, Chernyshov PV, Le Garrec R, Talagas M. Basic mechanisms of itch. J Allergy Clin Immunol 2023; 152: 11–23. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials